This inventor holds 6 USPTO granted patents. Top assignees: Eisai Company, Limited, Eisai R&d Management Co., Ltd.. Active years: 2005-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2010
Title: The Innovations of Sadakazu Miyashita
Introduction
Sadakazu Miyashita is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of carboxylic acid derivatives. With a total of 6 patents to his name, his work has the potential to impact the treatment of various health conditions.
Latest Patents
Miyashita's latest patents include innovative compounds that serve as insulin sensitizers. One of his key inventions is a carboxylic acid derivative, a salt thereof, or an ester of them, which is incorporated into a medicament. This invention provides novel carboxylic acid derivatives that are useful in enhancing insulin sensitivity. The specific formula and components of these compounds are detailed in his patent specifications, showcasing the complexity and potential of his work.
Career Highlights
Throughout his career, Sadakazu Miyashita has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Eisai Company, Limited and Eisai R&D Management Co., Ltd. His experience in these organizations has allowed him to collaborate on various research projects and contribute to advancements in medicinal chemistry.
Collaborations
Miyashita has collaborated with several professionals in his field, including Masanobu Shinoda and Eita Emori. These collaborations have likely enriched his research and led to the development of innovative solutions in the pharmaceutical sector.
Conclusion
Sadakazu Miyashita's contributions to the field of medicinal chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in treatments for health conditions, particularly in the area of insulin sensitivity.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

